Joshua S Everhart1, Eric Altneu, Jason H Calhoun. 1. Department of Orthopaedics, The Ohio State University Wexner Medical Center, 725 Prior Hall 376 West 10th Avenue, Columbus, OH, 43210, USA.
Abstract
BACKGROUND: Surgical site infection (SSI) after total joint arthroplasty (TJA) is a major cause of morbidity. Multiple patient comorbidities have been identified as SSI risk factors including obesity, tobacco use, diabetes, immunosuppression, malnutrition, and coagulopathy. However, the independent effect of multiple individual patient factors on risk of subsequent periprosthetic infection is unclear. QUESTIONS/PURPOSES: The purposes of this study are (1) to collect data on several preestablished infection risk factors in addition to SSI-related data on a large TJA cohort; and (2) to use multivariate modeling on previously established patient risk factors to determine independent preoperative predictors of SSI. METHODS: We reviewed records of patients undergoing TJA from January 1, 2010, to July 30, 2012. Confirmation of SSI followed published guidelines for superficial, deep, and periprosthetic. A total of 29 culture-positive SSIs (1.5% total) and 1846 controls were identified. The prevalence of known patient-specific infection risk factors was determined for both infected cases and healthy control subjects followed by multiple regression analysis to determine independent risk. RESULTS: Isolated organisms consisted of methicillin-resistant Staphylococcus aureus (MRSA; 34.5%) followed by gram-negative rods (31.0%). After adjusting for anatomic site, independent risk factors for infection include: revision surgery (odds ratio [OR], 2.28; confidence interval [CI], 1.26-3.98), super obesity (body mass index>50 kg/m2; OR, 5.28; CI, 1.38-17.1), diabetes mellitus (OR, 1.83; CI, 1.02-3.27), tobacco abuse (OR, 2.96; CI, 1.65-5.11), MRSA colonization or infection (OR, 4.17; CI, 1.63-9.66), and current or prior bone cancer (OR, 3.86; CI, 1.21-12.79). CONCLUSIONS: Multiple patient comorbidities independently contribute to infection risk after TJA. Preoperative TJA infection risk stratification may be feasible and should be investigated further. LEVEL OF EVIDENCE: Level II, prognostic study. See Guidelines for Authors for a complete description of levels of evidence.
BACKGROUND: Surgical site infection (SSI) after total joint arthroplasty (TJA) is a major cause of morbidity. Multiple patient comorbidities have been identified as SSI risk factors including obesity, tobacco use, diabetes, immunosuppression, malnutrition, and coagulopathy. However, the independent effect of multiple individual patient factors on risk of subsequent periprosthetic infection is unclear. QUESTIONS/PURPOSES: The purposes of this study are (1) to collect data on several preestablished infection risk factors in addition to SSI-related data on a large TJA cohort; and (2) to use multivariate modeling on previously established patient risk factors to determine independent preoperative predictors of SSI. METHODS: We reviewed records of patients undergoing TJA from January 1, 2010, to July 30, 2012. Confirmation of SSI followed published guidelines for superficial, deep, and periprosthetic. A total of 29 culture-positive SSIs (1.5% total) and 1846 controls were identified. The prevalence of known patient-specific infection risk factors was determined for both infected cases and healthy control subjects followed by multiple regression analysis to determine independent risk. RESULTS: Isolated organisms consisted of methicillin-resistant Staphylococcus aureus (MRSA; 34.5%) followed by gram-negative rods (31.0%). After adjusting for anatomic site, independent risk factors for infection include: revision surgery (odds ratio [OR], 2.28; confidence interval [CI], 1.26-3.98), super obesity (body mass index>50 kg/m2; OR, 5.28; CI, 1.38-17.1), diabetes mellitus (OR, 1.83; CI, 1.02-3.27), tobacco abuse (OR, 2.96; CI, 1.65-5.11), MRSA colonization or infection (OR, 4.17; CI, 1.63-9.66), and current or prior bone cancer (OR, 3.86; CI, 1.21-12.79). CONCLUSIONS: Multiple patient comorbidities independently contribute to infection risk after TJA. Preoperative TJA infection risk stratification may be feasible and should be investigated further. LEVEL OF EVIDENCE: Level II, prognostic study. See Guidelines for Authors for a complete description of levels of evidence.
Authors: Eric Fulkerson; Craig J Della Valle; Brent Wise; Michael Walsh; Charles Preston; Paul E Di Cesare Journal: J Bone Joint Surg Am Date: 2006-06 Impact factor: 5.284
Authors: E F Berbari; A D Hanssen; M C Duffy; J M Steckelberg; D M Ilstrup; W S Harmsen; D R Osmon Journal: Clin Infect Dis Date: 1998-11 Impact factor: 9.079
Authors: Reese W Randle; Shuja Ahmed; Edward A Levine; Nora F Fino; Katrina R Swett; John H Stewart; Perry Shen; Konstantinos I Votanopoulos Journal: J Surg Oncol Date: 2014-12-29 Impact factor: 3.454
Authors: Menachem M Meller; Nader Toossi; Mark H Gonzalez; Min-Sun Son; Edmund C Lau; Norman Johanson Journal: Clin Orthop Relat Res Date: 2016-08-25 Impact factor: 4.176